New obesity drug tested in asian and Non-Asian volunteers
NCT ID NCT07101783
First seen Jan 07, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This early-stage study tested a single dose of a new medicine, NNC0662-0419, in 100 adults with overweight or obesity. Researchers wanted to see how the drug behaves in the body and whether it is safe in Japanese, Chinese, and non-Asian participants. The study lasted up to 2 months and involved one injection under the skin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical LA, Inc.
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.